|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| The Crossroad of Biotechnology 2003 | ||||||||||||||||
| September 08, 2003 | ||||||||||||||||
|
Fondation Biotech Montréal / Biotechnology Research Institute, 6100 Royalmount, Montreal, Quebec 29-30 September, 2003 Biopharmaceuticals: Towards Enhanced Productivity and Commercialization Remodeling Discovery: Global overview, productivity assessment, product development strategies, reduction of R&D risk. Enabling Tools: Managing biological data, new biomarkers, pharmacodynamic models, imaging. Planning for Commercialization: Creating value, innovative measures, expanding technology applications, licensing-in strategy, acquisition approaches. Industry and Market Trends: Shifting from traditionals to therapeutics, contract manufacturing, access to market data. |
||||||||||||||||
| Organized by: | Fondation Biotech Montréal / Biotechnology Research Institute | |||||||||||||||
| Invited Speakers: | Over 20 speakers will be attending the Conference: Mr. André Marcheterre, President, MERCK FROSST CANADA LTD., Montréal, Quebec Dr. Prof. Juergen Drews, Consultant BEAR STEARNS Health Innoventures LLC, New York, USA Dr. Jan M. Lundberg, Executive Vice President, GLOBAL DISCOVERY RESEARCH, ASTRAZENECA R&D Headquarters, Södertälje, Sweden Dr. Daniel F. Veber, Drug Discovery Consultant, AMBLER, USA Dr. Ed. Pagani, Director, Strategic Alliances, Ann Arbor Laboratories, PFIZER INC., ANN ARBOR, USA
|
|||||||||||||||
| Deadline for Abstracts: | N/A | |||||||||||||||
| Registration: | crossroad@cnrc-nrc.gc.ca Website: www.crossroadbiotech.ca Tel: (514) 496-5329 Fax: (514) 496-5007 | |||||||||||||||
| E-mail: | crossroad@cnrc-nrc.gc.ca | |||||||||||||||
| Posted by: | Ani Armenian | |||||||||||||||
| Host: | irb191-30.bri.nrc.ca | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||